Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07633743 · ClinicalTrials.gov registry record · NA
MenoZen VR for Menopause Symptom Management: Phase 2
A NA study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07633743: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT07633743 is a NA study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07633743, a NA study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate the feasibility, acceptability, tolerability, and clinical efficacy of MenoZen VR (virtual reality) for managing menopause symptoms in women.
Interventions
- DEVICE MenoZen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-07-31 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07633743
The ClinicalTrials.gov registry entry for NCT07633743 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MenoZen is the first listed.
NCT07633743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07633743 about?
NCT07633743 is a clinical study titled "MenoZen VR for Menopause Symptom Management: Phase 2". The purpose of this research is to evaluate the feasibility, acceptability, tolerability, and clinical efficacy of MenoZen VR (virtual reality) for managing menopause symptoms in women.
What is the current status of trial NCT07633743?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-07-31. Estimated completion is 2028-07-31.
What interventions are being tested in trial NCT07633743?
The interventions under investigation include: MenoZen (DEVICE).
Who is sponsoring clinical trial NCT07633743?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.